Additional Oxerutin Therapy to Promote Deep Vein Thrombus Resolution – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Stephanie Carlin et al, adding:
“Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy alongside standard treatment reduced residual venous obstruction in deep vein thrombosis patients, potentially lowering postthrombotic syndrome risk compared to standard treatment alone.”
Title: Association of direct oral anticoagulant–anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study
Authors: Stephanie Carlin, Anne M. Holbrook, Matteo Candeloro, Francis Nguyen, Michael Paterson, James Douketis.
Read the Full Article on Journal of Thrombosis and Haemostasis.

Get the latest from Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics